Literature DB >> 12892995

Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways.

Jacques Alary1, Françoise Guéraud, Jean-Pierre Cravedi.   

Abstract

Due to the cytotoxicity of 4-hydroxynonenal (HNE), and to the fact that this major product of lipid peroxidation is a rather long-living compound compared with reactive oxygen species, the capability of organisms to inactivate and eliminate HNE has received increasing attention during the last decade. Several recent in vivo studies have addressed the issue of the diffusion, kinetics, biotransformation and excretion of HNE. Part of these studies are primarily concerned with the toxicological significance of HNE biotransformation and more precisely with the metabolic pathways by which HNE is inactivated and eliminated. The other aim of in vivo metabolic study is the characterisation of end-metabolites, especially in urine, in order to develop specific and non-invasive biomarkers of lipid peroxidation. When HNE is administered intravenously or intraperitoneally, it is mainly excreted into urine and bile as conjugated metabolites, in a proportion that is dependent on the administration route. However, biliary metabolites undergo an enterohepatic cycle that limits the final excretion of faecal metabolites. Only a very low amount of metabolites is found to be bound to macromolecules. The main urinary metabolites are represented by two groups of compounds. One comes from the mercapturic acid formation from (i) 1,4 dihydroxynonene-glutathione (DHN-GSH) which originates from the conjugation of HNE with GSH by glutathione-S-transferases and the subsequent reduction of the aldehyde by a member of aldo-keto reductase superfamily; (ii) the lactone of 4-hydroxynonanoic-GSH (HNA-lactone-GSH) which originates from the conjugation of HNE followed by the oxidation of the aldehyde by aldehyde dehydrogenase; (iii) HNA-GSH which originates from the hydrolysis of the corresponding lactone. The other one is a group of metabolites issuing from the omega-hydroxylation of HNA or HNA-lactone by cytochromes P450 4A, followed eventually, in the case of omega-oxidized-HNA-lactone, by conjugation with GSH and subsequent mercapturic acid formation. Biliary metabolites are GSH or mercapturic acid conjugates of DHN, HNE and HNA. Stereochemical aspects of HNE metabolism are also discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892995     DOI: 10.1016/s0098-2997(03)00012-8

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  43 in total

1.  Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal.

Authors:  Kirill Tsirulnikov; Natalia Abuladze; Anatol Bragin; Kym Faull; Duilio Cascio; Robert Damoiseaux; Matthew J Schibler; Alexander Pushkin
Journal:  Toxicol Appl Pharmacol       Date:  2012-07-20       Impact factor: 4.219

Review 2.  Protein carbonylation, mitochondrial dysfunction, and insulin resistance.

Authors:  Brigitte I Frohnert; David A Bernlohr
Journal:  Adv Nutr       Date:  2013-03-01       Impact factor: 8.701

3.  Dietary regulation of catabolic disposal of 4-hydroxynonenal analogs in rat liver.

Authors:  Qingling Li; Kristyen Tomcik; Shenghui Zhang; Michelle A Puchowicz; Guo-Fang Zhang
Journal:  Free Radic Biol Med       Date:  2012-01-04       Impact factor: 7.376

Review 4.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

5.  Vitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humans.

Authors:  Heather C Kuiper; Richard S Bruno; Maret G Traber; Jan F Stevens
Journal:  Free Radic Biol Med       Date:  2011-01-12       Impact factor: 7.376

6.  Adducts of oxylipin electrophiles to glutathione reflect a 13 specificity of the downstream lipoxygenase pathway in the tobacco hypersensitive response.

Authors:  Céline Davoine; Olivier Falletti; Thierry Douki; Gilles Iacazio; Najla Ennar; Jean-Luc Montillet; Christian Triantaphylidès
Journal:  Plant Physiol       Date:  2006-02-24       Impact factor: 8.340

Review 7.  Signaling by 4-hydroxy-2-nonenal: Exposure protocols, target selectivity and degradation.

Authors:  Hongqiao Zhang; Henry Jay Forman
Journal:  Arch Biochem Biophys       Date:  2016-11-10       Impact factor: 4.013

Review 8.  Analysis of endogenous glutathione-adducts and their metabolites.

Authors:  Ian A Blair
Journal:  Biomed Chromatogr       Date:  2010-01       Impact factor: 1.902

9.  A 4-oxo-2(E)-nonenal-derived glutathione adduct from 15-lipoxygenase-1-mediated oxidation of cytosolic and esterified arachidonic acid.

Authors:  Peijuan Zhu; Wenying Jian; Ian A Blair
Journal:  Free Radic Biol Med       Date:  2009-07-02       Impact factor: 7.376

10.  Modulation of keratinocyte expression of antioxidants by 4-hydroxynonenal, a lipid peroxidation end product.

Authors:  Ruijin Zheng; Diane E Heck; Vladimir Mishin; Adrienne T Black; Michael P Shakarjian; Ah-Ng Tony Kong; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2014-01-11       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.